Pasithea Therapeutics Corp. (KTTA) vs Jin Medical International Ltd. (ZJYL)
A side-by-side comparison of Pasithea Therapeutics Corp. and Jin Medical International Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KTTA
Pasithea Therapeutics Corp.
$0.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ZJYL
Jin Medical International Ltd.
$1.99HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — KTTA vs ZJYL
growth of $100 · dividends reinvested · last 4yKTTA -94.5% (-51.5%/yr)ZJYL -75.1% (-29.4%/yr)ZJYL compounded faster over this window
KTTA ZJYL
KTTA vs ZJYL: by the numbers
- •ZJYL is the larger company ($16M vs $15M market cap).
- •ZJYL is profitable (5.76% net margin) while KTTA runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | KTTA | ZJYL |
|---|---|---|
| P/B ratio | 0.30 | 0.51 |
Profitability
| Metric | KTTA | ZJYL |
|---|---|---|
| Gross margin | 0.00% | 29.22% |
| Operating margin | 0.00% | 2.94% |
| Net margin | 0.00% | 5.76% |
| ROE | -42.72% | 4.02% |
| ROIC | -48.04% | 1.09% |
Growth (annualized)
| Metric | KTTA | ZJYL |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 5.02% |
| EPS CAGR (5Y) | N/A | 6.40% |
| Total return CAGR (5Y) | -61.48% | N/A |
Frequently asked
- Is KTTA or ZJYL more profitable?
- ZJYL runs the higher net margin — KTTA at 0.00% versus ZJYL at 5.76%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.